Abstract
Mice were injected intravenously with Candida albicans blastospores to establish chronic renal infection. Seventy-five percent of the animals inoculated with 10(6) blastospores died as a consequence of infection during the subsequent 60 days of observation. Intraperitoneal administration of 10 mU of partially purified human myeloperoxidase 1 day after injection of the pathogen increased survival of the mice from 25 to 80% over this time period. Administration of myeloperoxidase complexed with soluble C. albicans cell wall mannan abrogated the protective influence of the enzyme. These results demonstrate that exogenous myeloperoxidase has a therapeutic influence on murine renal candidiasis and suggest that exogenous myeloperoxidase may also be effective in the treatment of certain forms of candidiasis in humans. These results also demonstrate the important role of the mannan-binding function of myeloperoxidase for effective treatment of candidiasis and suggest a mechanism of inhibition of the candidacidal effect of free enzyme in vivo by mannan accumulating in tissue fluids.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Andrews P. C., Krinsky N. I. The reductive cleavage of myeloperoxidase in half, producing enzymically active hemi-myeloperoxidase. J Biol Chem. 1981 May 10;256(9):4211–4218. [PubMed] [Google Scholar]
- Baggiolini M., Hirsch J. G., De Duve C. Resolution of granules from rabbit heterophil leukocytes into distinct populations by zonal sedimentation. J Cell Biol. 1969 Feb;40(2):529–541. doi: 10.1083/jcb.40.2.529. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Klebanoff S. J. Myeloperoxidase-halide-hydrogen peroxide antibacterial system. J Bacteriol. 1968 Jun;95(6):2131–2138. doi: 10.1128/jb.95.6.2131-2138.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lehrer R. I. Antifungal effects of peroxidase systems. J Bacteriol. 1969 Aug;99(2):361–365. doi: 10.1128/jb.99.2.361-365.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Okuda K., Ishiwara K., Noguchi Y., Takahashi T., Tadokoro I. New type of antibody-enzyme conjugate which specifically kills Candida albicans. Infect Immun. 1980 Feb;27(2):690–692. doi: 10.1128/iai.27.2.690-692.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Selvaraj R. J., Zgliczynski J. M., Paul B. B., Sbarra A. J. Enhanced killing of myeloperoxidase-coated bacteria in the myeloperoxidase-H2O2-Cl- system. J Infect Dis. 1978 Apr;137(4):481–485. doi: 10.1093/infdis/137.4.481. [DOI] [PubMed] [Google Scholar]
- Wright C. D., Bowie J. U., Gray G. R., Nelson R. D. Candidacidal activity of myeloperoxidase: mechanisms of inhibitory influence of soluble cell wall mannan. Infect Immun. 1983 Oct;42(1):76–80. doi: 10.1128/iai.42.1.76-80.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wright C. D., Bowie J. U., Nelson R. D. Influence of yeast mannan on release of myeloperoxidase by human neutrophils: determination of structural features of mannan required for formation of myeloperoxidase-mannan-neutrophil complexes. Infect Immun. 1984 Feb;43(2):467–471. doi: 10.1128/iai.43.2.467-471.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wright C. D., Herron M. J., Gray G. R., Holmes B., Nelson R. D. Influence of yeast mannan on human neutrophil functions: inhibition of release of myeloperoxidase related to carbohydrate-binding property of the enzyme. Infect Immun. 1981 May;32(2):731–738. doi: 10.1128/iai.32.2.731-738.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]